We've found
52,953 Cancer
clinical trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Carcinoma Clinical Trial
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Body Composition and White Adipose Tissue Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Clinician-Patient Communication in Lung Cancer Care
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
Status: Enrolling,
Phase
I
Updated: 3/14/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Patients With Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Her2 Positive Breast Cancer Clinical Trial
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling,
Phase
III
Updated: 5/22/2017
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Trial to Evaluate the Safety ofTalimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic Pembrolizumab
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
NASOPHARYNGEAL CARCINOMA Clinical Trial
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
52,953 Cancer
clinical trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 12/31/1969
A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Carcinoma Clinical Trial
Updated: 12/31/1969
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Body Composition and White Adipose Tissue Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Updated: 12/31/1969
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Updated: 12/31/1969
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Updated: 12/31/1969
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Updated: 12/31/1969
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
Clinician-Patient Communication in Lung Cancer Care
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
Updated: 7/29/2015
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
Updated: 7/29/2015
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
Updated: 7/29/2015
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 3/14/2018
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
Status: Enrolling,
Phase
I
Updated: 3/14/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 4/18/2018
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Updated: 12/31/1969
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Updated: 12/31/1969
Selinexor in Advanced Liposarcoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Patients With Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Updated: 12/31/1969
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Her2 Positive Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 4/1/2016
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling,
Phase
IV
Updated: 4/1/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 5/22/2017
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling,
Phase
III
Updated: 5/22/2017
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
Updated: 12/31/1969
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
Updated: 12/31/1969
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
Updated: 12/31/1969
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Trial to Evaluate the Safety ofTalimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic Pembrolizumab
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
NASOPHARYNGEAL CARCINOMA Clinical Trial
Updated: 12/31/1969
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Updated: 12/31/1969
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Updated: 12/31/1969
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials